MedPath

Evaluation of curcumin gel effevtiveness in prophylaxis of radiation dermatitis

Phase 3
Conditions
Dermatitis caused by breast radiation therapy.
Radiodermatitis
Registration Number
IRCT20181208041882N3
Lead Sponsor
Yazd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
60
Inclusion Criteria

Women 18 to 65 years old to get started breast radiation therapy has been referred to Shahid Ramezanzadeh Radiotherapy Center in Yazd

Exclusion Criteria

People with skin diseases
People who are allergic to curcumin
People with severe systemic diseases such as uncontrolled diabetes

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath